Stone Run Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$4.8M Sell
16,705
-1,350
-7% -$362K 1.89% 25
2025
Q2
$4.74M Buy
18,055
+2,850
+19% +$694K 1.89% 24
2025
Q1
$3.54M Buy
+15,205
New +$3.69M 1.49% 30
2020
Q1
Sell
-20,122
Closed -$2.92M 60
2019
Q4
$2.92M Hold
20,122
1.3% 35
2019
Q3
$2.9M Hold
20,122
1.38% 34
2019
Q2
$2.99M Buy
20,122
+14
+0.1% +$1.95K 1.36% 36
2019
Q1
$2.64M Sell
20,108
-14
-0.1% -$1.73K 1.3% 36
2018
Q4
$2.19M Sell
20,122
-4,772
-19% -$639K 1.36% 33
2018
Q3
$3.71M Buy
24,894
+174
+0.7% +$26.5K 1.71% 31
2018
Q2
$3.81M Sell
24,720
-58
-0.2% -$8.76K 2.01% 26
2018
Q1
$3.44M Buy
24,778
+2,444
+11% +$359K 1.81% 27
2017
Q4
$3.06M Hold
22,334
1.57% 35
2017
Q3
$2.9M Sell
22,334
-58
-0.3% -$7.74K 1.49% 35
2017
Q2
$2.96M Hold
22,392
1.64% 31
2017
Q1
$2.76M Sell
22,392
-116
-0.5% -$13.7K 1.66% 32
2016
Q4
$2.48M Sell
22,508
-5,617
-20% -$624K 1.62% 30
2016
Q3
$3.32M Sell
28,125
-931
-3% -$110K 2.07% 22
2016
Q2
$3.25M Sell
29,056
-7,682
-21% -$827K 2.12% 22
2016
Q1
$3.68M Sell
36,738
-17,111
-32% -$1.64M 2.37% 12
2015
Q4
$5.72M Buy
53,849
+4,656
+9% +$480K 3.97% 2
2015
Q3
$4.58M Buy
49,193
+7,915
+19% +$819K 3.64% 4
2015
Q2
$4.3M Sell
41,278
-2,852
-6% -$297K 2.82% 9
2015
Q1
$4.78M Buy
44,130
+10,130
+30% +$1.04M 3.08% 4
2014
Q4
$3.15M Buy
+34,000
New +$3M 2.17% 12
2014
Q3
Sell
-7,566
Closed -$666K 85
2014
Q2
$666K Buy
+7,566
New +$655K 0.44% 63

Other funds holding LH

Stone Run Capital's LH Position: Q3 2025 in Review

Stone Run Capital reduced its Labcorp (LH) stake by 7.5% in Q3 2025, selling an estimated $362K and leaving 16,705 shares worth $4.8M. The position accounts for 1.89% of the portfolio, ranked #25.

Stone Run Capital first reported a position in LH in Q2 2014 and has held it in 25 quarters since. The position peaked at $5.72M in Q4 2015. 1,009 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Stone Run Capital held 16,705 shares of Labcorp worth $4.8M as of Q3 2025.
  • Stone Run Capital sold 1,350 Labcorp shares in Q3 2025, an estimated $362K.
  • Labcorp made up 1.89% of Stone Run Capital's portfolio in Q3 2025, its #25 holding.
  • Stone Run Capital first reported a position in Labcorp in Q2 2014 and has held it in 25 quarters since.
  • Stone Run Capital's Labcorp position peaked at $5.72M in Q4 2015.
  • 1,009 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Stone Run Capital's 13F filing for Q3 2025, filed 14 Nov 2025.